Literature DB >> 6849729

Anaphylaxis caused by anti-cremophor EL IgG STS antibodies in a case of reaction to althesin.

D A Moneret-Vautrin, M C Laxenaire, F Viry-Babel.   

Abstract

The action of cremophor EL, the solubilizing agent of Althesin in a case of anaphylactic reaction which occurred during the induction of anaesthesia has been demonstrated using the Prausnitz-Küstner (P-K) test 10 weeks later. This test was positive at 2 h, with the heated serum and cremophor, proving the presence of allergic IgG STS antibodies.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6849729     DOI： 10.1093/bja/55.5.469

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN： 0007-0912            Impact factor:   9.166


  7 in total

Review 1.  Pharmaceutical excipients. Adverse effects associated with 'inactive' ingredients in drug products (Part II).

Authors:  L K Golightly; S S Smolinske; M L Bennett; E W Sutherland; B H Rumack
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 May-Jun

Review 2.  Place of excipients in drug-related allergy.

Authors:  A Barbaud
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

3.  Continuous Rate Infusion of Alfaxalone during Ketamine-Xylazine Anesthesia in Rats.

Authors:  Kathleen Heng; James O Marx; Katechan Jampachairsi; Monika K Huss; Cholawat Pacharinsak
Journal:  J Am Assoc Lab Anim Sci       Date:  2020-02-14       Impact factor: 1.232

4.  Residue mass plot and abundance plot: detection of isobaric interferences in DE-MALDI-TOF-mass spectra of complex polymer mixtures.

Authors:  T Meyer; M Kunkel; A W Frahm; D Waidelich
Journal:  J Am Soc Mass Spectrom       Date:  2001-08       Impact factor: 3.109

5.  Effects of polysorbates and Cremophor EL on vascular responses in rat aorta.

Authors:  H Zengil; U Hodoğlugil; Z Güney
Journal:  Experientia       Date:  1995-11-15

6.  Liposomal formulation eliminates acute toxicity and pump incompatibility of parenteral cyclosporine.

Authors:  S A Gruber; S Venkataram; D M Canafax; R J Cipolle; L Bowers; D Elsberry; M McGuiggan; P E Hynes; J A Ritz; F H Gould
Journal:  Pharm Res       Date:  1989-07       Impact factor: 4.200

7.  Bioequivalence and tolerability assessment of a novel intravenous ciclosporin lipid emulsion compared to branded ciclosporin in Cremophor ® EL.

Authors:  Karl Henrik Johannes Ehinger; Magnus Joakim Hansson; Fredrik Sjövall; Eskil Elmér
Journal:  Clin Drug Investig       Date:  2013-01       Impact factor: 2.859
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.